Intra-dermal Injections of DLX105 Into Lesional Skin in Patients With Mild-to-moderate Psoriasis Vulgaris

Clinical trial NCT01595997 · COMPLETED

Trial details

NCT number: NCT01595997
Sponsor: Delenex Therapeutics AG
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Mild-to-moderate Psoriasis Vulgaris

Start date: 2012-02-01
Primary completion: 2012-08-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.